Global Injectable Cement Market Size By Type (Low Viscosity Cements, Medium Viscosity Cements), By Application (Periprosthetic Fractures, Pelvic Fractures), By Region, And Segment Forecasts, 2023 to 2...

lobal Injectable Cement Market

The Global Injectable Cement Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.1 billion by 2031, growing at a CAGR of 8.3% during the forecast period from 2023 to 2031. The demand for injectable cement is rising due to the growing prevalence of orthopedic conditions, increasing geriatric population, and expanding use of minimally invasive surgical techniques. Injectable cement plays a vital role in procedures such as vertebroplasty and kyphoplasty, providing mechanical support and pain relief, particularly in cases of osteoporotic fractures.

Drivers

1. Rising Incidence of Osteoporosis and Orthopedic Conditions

With aging populations worldwide, the incidence of conditions such as osteoporosis, spinal compression fractures, and degenerative bone diseases is increasing. Injectable cements are widely used in treating these ailments, especially among elderly patients.

2. Advancements in Minimally Invasive Surgeries

The shift toward minimally invasive surgical techniques has fueled the adoption of injectable cements. These procedures reduce recovery time, minimize surgical complications, and offer effective pain management.

3. Expanding Applications Beyond Orthopedics

While initially developed for spinal procedures, injectable cement is now being utilized in trauma surgery, oncology-related bone treatments, and dental applications, creating new revenue opportunities.

Restraints

1. Risk of Complications and Cement Leakage

Despite their benefits, injectable cements carry risks such as cement leakage, pulmonary embolism, and adverse reactions, which may discourage usage and regulatory acceptance in some markets.

2. High Product and Procedure Costs

The overall cost of treatment using injectable cement—including the material itself and associated surgical equipment—can be prohibitive, especially in low-income regions with underfunded healthcare systems.

Opportunity

1. Emerging Markets and Healthcare Infrastructure Development

Emerging economies in Asia-Pacific and Latin America are investing heavily in healthcare infrastructure, opening new avenues for injectable cement manufacturers to expand their footprint.

2. Innovation in Biocompatible and Resorbable Cements

R&D in developing bioresorbable and highly biocompatible cement formulations is expected to reshape the market, offering safer alternatives with enhanced clinical outcomes.

Market by System Type Insights

Based on system type, the Polymethyl Methacrylate (PMMA) cement segment accounted for the largest market share in 2023. PMMA remains the most widely used injectable cement due to its high compressive strength, ease of handling, and long-standing clinical acceptance. However, the calcium phosphate cement segment is projected to register the highest CAGR during the forecast period due to its biodegradability and compatibility with bone tissue.

Market by End-use Insights

By end-use, hospitals and orthopedic clinics dominated the global injectable cement market in 2023, representing more than 60% of revenue share. The prevalence of specialized surgical units and access to advanced technologies makes hospitals the preferred setting for cement-based treatments. The ambulatory surgical centers (ASCs) segment is expected to grow rapidly, supported by the trend toward outpatient care and reduced surgical costs.

Market by Regional Insights

Geographically, North America held the largest share of the global injectable cement market in 2023, driven by its robust healthcare infrastructure, higher diagnosis rates of spinal disorders, and rapid adoption of minimally invasive techniques. Meanwhile, Asia-Pacific is poised to witness the fastest growth during the forecast period, fueled by increasing healthcare investments, rising geriatric population, and growing awareness of spinal health.

Competitive Scenario

Prominent players in the global injectable cement market include:

Stryker Corporation

DePuy Synthes (Johnson & Johnson)

Zimmer Biomet Holdings, Inc.

Teknimed

Heraeus Medical GmbH

DJO Global, Inc.

G21 S.r.l.

Globus Medical, Inc.

SOMATEX Medical Technologies GmbH

GPC Medical Ltd.

These companies are focusing on strategic mergers, product innovations, and geographic expansion to strengthen their competitive positions. Recent advancements include the development of resorbable and antibiotic-loaded cements to reduce post-operative infections and improve bone regeneration.

Scope of Work – Global Injectable Cement Market

Key Market Developments

2023: Stryker launched a next-gen PMMA-based cement with improved flowability for minimally invasive procedures.

2024: Zimmer Biomet announced a strategic partnership with a biotech firm to develop calcium phosphate-based injectable cements.

2025: Teknimed introduced antibiotic-loaded injectable cement, reducing post-op infection rates in high-risk orthopedic surgeries.

FAQs

1) What is the current market size of the Global Injectable Cement Market?

The market size was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Injectable Cement Market?

The major growth driver is the rising prevalence of orthopedic conditions and the adoption of minimally invasive surgical procedures.

3) Which is the largest region during the forecast period in the Global Injectable Cement Market?

North America is expected to remain the largest regional market.

4) Which segment accounted for the largest market share in the Global Injectable Cement Market?

The PMMA segment accounted for the largest share by system type in 2023.

5) Who are the key market players in the Global Injectable Cement Market?

Key players include Stryker, DePuy Synthes, Zimmer Biomet, Teknimed, and Heraeus Medical.

Let me know if you’d like this exported as a DOCX or formatted for presentation.